ARSci  Vol.1 No.3 , November 2013
Decidual cell expressed tissue factor promotes endometrial hemostasis while mediating abruption associated preterm birth
Abstract: During human pregnancy, progesterone induced decidual cells protect against hemorrhage: 1) as endovascular trophoblast breech and remodel uterine blood vessels; and 2) in the third stage of labor following preterm and term delivery. De- cidual cells promote hemostasis through enhanced expression of tissue factor (TF), the primary initiator of hemostasis via thrombin generation, and plasminogen activator inhibitor-1, which inactivates tissue type plasminogen activator, the primary fibrinolytic agent. Abruptions (decidual hemorrhage) produce excess thrombin which acts as autocrine/paracrine inducer of decidual cell expressed matrix metalloproteinases and of neutrophil chemoattractant and activator, interleukin-8. The latter mediates aseptic abruption-related neutrophil infiltration. During abruptions, decidual cell and neutrophil-derived proteases effectively degrade the decidual and fetal membrane extracellular matrix to promote preterm premature rupture of the membranes and preterm delivery (PTD). Decidual cell-derived thrombin weakens the amniotic membrane and lowers decidual cell-expressed progesterone receptor levels by increasing phospho-ERK1/2 signaling. The resulting functional progesterone withdrawal accompanies PTD.
Cite this paper: Faramarzi, S. , A. Kayisli, U. , Kayisli, O. , Basar, M. , Shapiro, J. , Semerci, N. , Huang, J. , Piao, L. , Schatz, F. and J. Lockwood, C. (2013) Decidual cell expressed tissue factor promotes endometrial hemostasis while mediating abruption associated preterm birth. Advances in Reproductive Sciences, 1, 44-50. doi: 10.4236/arsci.2013.13007.

[1]   Bell, S. (1990) Contraception and mechanisms of endometrial bleeding. In: D’Arcangues, C., et al., Eds., Decidualization and Relevance to Menstruation, Cambridge University Press, Cambridge, 188.

[2]   Tabanelli, S., Tang, B. and Gurpide, E. (1992) In vitro decidualization of human endometrial stromal cells. The Journal of Steroid Biochemistry and Molecular Biology, 42, 337-344.

[3]   Mackman, N., Tilley, R.E. and Key, N.S. (2007) Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1687-1693.

[4]   Tilley, R. and Mackman, N. (2006) Tissue factor in hemostasis and thrombosis. Semin Thromb Hemost, 32, 5-10.

[5]   Mignatti, P. and Rifkin, D.B. (1993) Biology and biochemistry of proteinases in tumor invasion. Physiological Review, 73, 161-195.

[6]   Mackman, N. (2004) Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterio-sclerosis, Thrombosis, and Vascular Biology, 24, 1015-1022.

[7]   Moore (1988) The developing human: Clinically oriented embryology, 4th Edition, 40.

[8]   Levy, A.P., Levy, N.S. and Goldberg, M.A. (1996) Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. Journal of Biological Chemistry, 271, 2746-2753.

[9]   Oka, C., et al. (1991) Chemical abortion in patients with recurrent fetal loss. Nihon Sanka Fujinka Gakkai Zasshi, 43, 239-240.

[10]   Pijnenborg, R., Vercruysse, L. and Hanssens, M. (2006) The uterine spiral arteries in human pregnancy: Facts and controversies. Placenta, 27, 939-958.

[11]   Brosens, I.A., Robertson, W.B. and Dixon, H.G. (1972) The role of the spiral arteries in the pathogenesis of preeclampsia. Obstetrical and Gynecological Annals, 1, 177- 191.

[12]   Edmonds, D.K., et al. (1982) Early embryonic mortality in women. Fertility and Sterility, 38, 447-453.

[13]   Miller, J.F., et al. (1980) Fetal loss after implantation: A prospective study. The Lancet, 316, 554-556.

[14]   Shanklin, D.R. and Scott, J.S. (1975) Massive subchorial thrombo-haematoma (Breus’ mole). British Journal of Obstetrics and Gynecology, 82, 476-487.

[15]   Lockwood, C.J., et al. (2009) Progestin and thrombin regulate tissue factor expression in human term decidual cells. Journal of Clinical Endocrinology & Metabolism, 94, 2164-2170.

[16]   Coughlin, S.R. (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. Journal of Thrombosis and Haemostasis, 3, 1800-1814.

[17]   Macfarlane, S.R., et al. (2001) Proteinase-activated receptors. Pharmacological Review, 53, 245-282.

[18]   Lockwood, C.J., et al. (1996) Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential. The Journal of Clinical Endocrinology & Metabolism, 81, 107-112.

[19]   Lockwood, C.J., et al. (2002) Differential effects of thrombin and hypoxia on en-dometrial stromal and glandular epithelial cell vascular endothelial growth factor expression. The Journal of Clinical Endocrinology & Metabolism, 87, 4280-4286.

[20]   Clark, P. (2003) Changes of hemostasis variables during pregnancy. Seminars in Vascular Medicine, 3, 13-24.

[21]   Bremme, K., et al. (1992) Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstetrics & Gynecology, 80, 132-137.

[22]   AR, K. and Drukker, J.E. (1986) Bleeding in late pregnancy: Antepartum bleeding. In: RH, H. and MS, C., Eds., High Risk Pregnancy: A Team Approach, Saunders, Philadelphia, 547.

[23]   R, F. and W, R. (1989) Bleeding during the latter half of pregnancy. In: C, I., Ed., High Risk Pregnancy: A Team Approach, Oxford University Press, London, 89.

[24]   Ananth, C.V., et al. (2007) Recurrence of ischemic placental disease. Obstetrics & Gynecology, 110, 128-133.

[25]   Harger, J.H., et al. (1990) Risk factors for preterm premature rupture of fetal membranes: A multicenter case-control study. American Journal of Obstetrics and Gynecology, 163, 130-137.

[26]   Williams, M.A., et al. (1991) Adverse infant outcomes associated with first-trimester vaginal bleeding. Obstetrics & Gynecology, 78, 14-18.

[27]   Salafia, C.M., et al. (1995) Histologic evidence of old intrauterine bleeding is more frequent in prematurity. American Journal of Obstetrics and Gynecology, 173, 1065- 1070.

[28]   Rosen, T., et al. (2001) Plasma levels of thrombinantithrombin complexes predict preterm premature rupture of the fetal membranes. Journal of Maternal-Fetal Medicine, 10, 297-300.

[29]   Elovitz, M.A., et al. (2000) The mechanisms underlying the stimulatory effects of thrombin on myometrial smooth muscle. American Journal of Obstetrics and Gynecology, 183, 674-681.

[30]   Hall, D.R. (2009) Abruptio placentae and disseminated intravascular coagulopathy. Seminars in Perinatology, 33, 189-195.

[31]   Rasmussen, S., et al. (1996) The occurrence of placental abruption in Norway 1967-1991. Acta Obstetricia et Gynecologica Scan-dinavica, 75, 222-228.

[32]   Ananth Cv, B.G.S.S.D.A.L.R.H. (1999) PLacental abruption and adverse perinatal outcomes. JAMA: The Journal of the American Medical Association, 282, 1646-1651.

[33]   Ananth, C.V., et al. (2005) Trends in twin preterm birth subtypes in the United States, 1989 through 2000: Impact on perinatal mortality. American Journal of Obstetrics and Gynecology, 193, 1076.e1-1076.e9.

[34]   Oyelese, Y. and Ananth, C.V. (2006) Placental abruption. Obstetrics & Gynecology, 108, 1005-1016.

[35]   Brosens, I., et al. (2011) The “Great Obstetrical Syndromes” are associated with disorders of deep placenta- tion. American Journal of Obstetrics and Gynecology, 204, 193-201.

[36]   Naeye, R.L. (1983) Maternal age, obstetric complications, and the outcome of pregnancy. Obstetrics & Gynecology, 61, 210-216.

[37]   Roque, H., et al. (2004) Maternal thrombophilias are not associated with early pregnancy loss. Thrombosis and Haemostasis, 91, 290-295.

[38]   Lykke, J.A., Paidas, M.J. and Langhoff-Roos, J. (2009) Recurring complications in second pregnancy. Obstetrics & Gynecology, 113, 1217-1224.

[39]   Ray, J.G., et al. (2005) Cardiovascular health after maternal placental syndromes (CHAMPS): Population-based retrospective cohort study. Lancet, 366, 1797-1803.

[40]   Tikkanen, M., et al. (2009) Maternal deaths in Finland: Focus on placental abruption. Acta Obstetricia et Gynecologica Scandina-vica, 88, 1124-1127.

[41]   Rosen, T., et al. (2002) Thrombin-enhanced matrix metalloproteinase-1 expression: A mechanism linking placental abruption with premature rupture of the mem- branes. Journal of Maternal-Fetal and Neonatal Medicine, 11, 11-17.

[42]   Mackenzie, A.P., et al. (2004) Mechanisms of abruption-induced premature rupture of the fetal membranes: Thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. American Journal of Obstet- rics and Gynecology, 191, 1996-2001.

[43]   Lockwood, C.J., et al. (2005) Mechanisms of abruption-induced premature rupture of the fetal membranes: Thrombin-enhanced interleukin-8 expression in term decidua. The American Journal of Pathology, 167, 1443- 1449.

[44]   Baggiolini, M., Walz, A. and Kunkel, S.L. (1989) Neutro-phil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. The Journal of Clinical Investigation, 84, 1045-1049.

[45]   Van den Steen, P.E., et al. (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO- alpha and leaves RANTES and MCP-2 intact. Blood, 96, 2673-2681.

[46]   Westermarck, J. and Kahari, V.M. (1999) Regulation of matrix metalloproteinase expression in tumor invasion. The FASEB Journal, 13, 781-792.

[47]   Cohen, M., Meisser, A. and Bischof, P. (2006) Metallo-proteinases and human placental invasiveness. Placenta, 27, 783-793.

[48]   Nagase, H., Visse, R. and Murphy, G. (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovascular Research, 69, 562-573.

[49]   Kumar, D., et al. (2011) The effects of thrombin and cytokines upon the biomechanics and remodeling of isolated amnion membrane, in vitro. Placenta, 32, 206-213.

[50]   Phillippe, M., Elovitz, M. and Saunders, T. (2001) Thrombin-stimulated uterine contractions in the pregnant and nonpregnant rat. Journal of the Society for Gynecologic Investigation, 8, 260-265.

[51]   Elovitz, M.A., et al. (2000) Effects of thrombin on myometrial contractions in vitro and in vivo. American Journal of Obstetrics & Gynecology, 183, 799-804.

[52]   Thijssen, J.H. (2005) Progesterone receptors in the human uterus and their possible role in parturition. The Journal of Steroid Biochemistry and Molecular Biology, 97, 397-400.

[53]   Mesiano, S., et al. (2002) Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. The Journal of Clinical Endocrinology & Metabolism, 87, 2924-2930.

[54]   Lockwood, C.J., et al. (2012) Abruption-induced preterm delivery is associated with thrombin-mediated functional progesterone withdrawal in decidual cells. The American Journal of Pathology, 181, 2138-2148.

[55]   Eckert, R.L. and Katzenellenbogen, B.S. (1981) Human endometrial cells in primary tissue culture: Modulation of the progesterone receptor level by natural and synthetic estrogens in vitro. The Journal of Clinical Endocrinology & Metabolism, 52, 699-708.